Paniagua-Vega David, Huerta-Heredia Ariana Arlene, Sánchez-Otero María Guadalupe, Waksman-Minsky Noemí, Lucio-Gutiérrez J Ricardo, Saucedo Alma L
Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Ciudad de México, México.
Facultad de Medicina, Depto. de Química Analítica, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, Nuevo León, México.
Magn Reson Chem. 2025 Jul;63(8):593-603. doi: 10.1002/mrc.5538. Epub 2025 May 29.
Verbascoside and isoverbascoside are phenylethanoid glycosides with reported biological activities such as neuroprotection, hepatoprotection, anti-inflammatory, antimicrobial, anticancer, and antioxidant properties. These compounds are constitutively present in roots, stems, leaves, and flowers of various plant species, including Tecoma stans. In Mexico, this plant is traditionally used as a safe and effective herbal treatment for chronic diseases and its complications including diabetes and renal and hepatic disorders. The potential pharmacological applications of verbascoside and isoverbascoside have conducted efforts to produce these compounds in cell and plant tissue cultures. In this study, T. stans root and plantlet in vitro cultures were established as potential sources of verbascoside and isoverbascoside, and NMR was used as primary analytical tool. As a first step, proton and bidimensional NMR analysis confirmed the presence of verbascoside and isoverbascoside in T. stans in vitro culture extracts. Subsequently, their contents were quantified by means of quantitative NMR (qNMR) based on the external standard PULCON method. Furthermore, H-NMR spectral data were used to develop a descriptive PLS-DA model, which confirms the qNMR results. This model indicated that differences in the amounts and proportions of verbascoside and isoverbascoside produced by roots and plantlets are the primary factors in distinguishing these samples. These results demonstrate the capability of T. stans in vitro systems as biotechnological tools for obtaining phenylethanoids with high pharmacological potential and confirm the broad applicability of NMR as an analytical platform. However, additional experiments are necessary to improve the phenylethanoids glucoside yields and support the validation of the qNMR method.
毛蕊花糖苷和异毛蕊花糖苷是苯乙醇苷类化合物,具有神经保护、肝脏保护、抗炎、抗菌、抗癌和抗氧化等多种已报道的生物活性。这些化合物在包括黄花凌霄在内的多种植物的根、茎、叶和花中均有组成性存在。在墨西哥,这种植物传统上被用作治疗慢性病及其并发症(包括糖尿病以及肾脏和肝脏疾病)的安全有效的草药。毛蕊花糖苷和异毛蕊花糖苷的潜在药理应用促使人们努力在细胞和植物组织培养中生产这些化合物。在本研究中,建立了黄花凌霄根和幼苗的体外培养体系,作为毛蕊花糖苷和异毛蕊花糖苷的潜在来源,并将核磁共振(NMR)用作主要分析工具。第一步,质子和二维NMR分析证实了黄花凌霄体外培养提取物中存在毛蕊花糖苷和异毛蕊花糖苷。随后,基于外标PULCON方法,通过定量核磁共振(qNMR)对它们的含量进行了定量。此外,利用氢核磁共振(H-NMR)光谱数据建立了描述性偏最小二乘判别分析(PLS-DA)模型,该模型证实了qNMR的结果。该模型表明,根和幼苗产生的毛蕊花糖苷和异毛蕊花糖苷在数量和比例上的差异是区分这些样品的主要因素。这些结果证明了黄花凌霄体外培养体系作为获取具有高药理潜力苯乙醇苷类化合物的生物技术工具的能力,并证实了核磁共振作为分析平台的广泛适用性。然而,并需要进行额外的实验来提高苯乙醇苷类糖苷的产量,并支持qNMR方法的验证。